Japan
Our Mission
We partner with emerging biotechs developing breakthrough medicines to improve health outcomes for Japanese patients. With deep expertise and local insights, we streamline the path to market, accelerating approvals and commercialization. Our approach tackles drug lag and drug loss, addressing critical unmet needs in Japan’s healthcare
Why partner with us?
Led by Ichiro Umeda from Japan and Avanish Mishra from the USA, our team combines deep cross-cultural expertise, seamlessly bridging Western and Japanese business practices to deliver exceptional results in Japan. With a proven track record of successfully launching multiple drugs for multinational biopharma companies in the region, we bring extensive commercialization expertise to every project.
Our Approach
Our strong industry network also provides access to key stakeholders across Japan’s biopharma ecosystem, including regulators and thought leaders, ensuring comprehensive support and strategic impact.